TY - JOUR
T1 - Downstream processing of lentiviral vectors
T2 - Releasing bottlenecks
AU - Bandeira, Vanessa
AU - Peixoto, Cristina
AU - Rodrigues, Ana F.
AU - Cruz, Pedro E.
AU - Alves, Paula M.
AU - Coroadinha, Ana S.
AU - Carrondo, Manuel J.T.
PY - 2012/8/1
Y1 - 2012/8/1
N2 - Lentiviral vectors (LVs) hold great potential as gene delivery vehicles. However, the manufacturing and purification of these vectors still present major challenges, mainly because of the low stability of the virus, essentially due to the fragility of the membrane envelope. The main goal of this work was the establishment of a fast, scalable, and robust downstream protocol for LVs, combining microfiltration, anion-exchange, and ultrafiltration membrane technologies toward maximization of infectious LVs recovery. CIM® (Convective Interaction Media) monolithic columns with diethylaminoethanol (DEAE) anion exchangers were used for the purification of clarified LV supernatants, allowing infectious vector recoveries of 80%, which is 10% higher than the values currently reported in the literature. These recoveries, combined with the results obtained after optimization of the remaining downstream purification steps, resulted in overall infectious LV yields of 36%. Moreover, the inclusion of a Benzonase step allowed a removal of approximately 99% of DNA impurities. The entire downstream processing strategy herein described was conceived based on disposable and easily scalable technologies. Overall, CIM DEAE columns have shown to be a good alternative for the purification of LVs, since they allow faster processing of the viral bulks and enhanced preservation of virus biological activity, consequently, increasing infectious vector recoveries.
AB - Lentiviral vectors (LVs) hold great potential as gene delivery vehicles. However, the manufacturing and purification of these vectors still present major challenges, mainly because of the low stability of the virus, essentially due to the fragility of the membrane envelope. The main goal of this work was the establishment of a fast, scalable, and robust downstream protocol for LVs, combining microfiltration, anion-exchange, and ultrafiltration membrane technologies toward maximization of infectious LVs recovery. CIM® (Convective Interaction Media) monolithic columns with diethylaminoethanol (DEAE) anion exchangers were used for the purification of clarified LV supernatants, allowing infectious vector recoveries of 80%, which is 10% higher than the values currently reported in the literature. These recoveries, combined with the results obtained after optimization of the remaining downstream purification steps, resulted in overall infectious LV yields of 36%. Moreover, the inclusion of a Benzonase step allowed a removal of approximately 99% of DNA impurities. The entire downstream processing strategy herein described was conceived based on disposable and easily scalable technologies. Overall, CIM DEAE columns have shown to be a good alternative for the purification of LVs, since they allow faster processing of the viral bulks and enhanced preservation of virus biological activity, consequently, increasing infectious vector recoveries.
KW - CLINICAL-APPLICATION
KW - MEMBRANE
KW - CELL
KW - RETROVIRAL VECTORS
KW - CHROMATOGRAPHY
KW - FILTRATION
KW - PURIFICATION
KW - STABILITY
KW - GENE-THERAPY VECTORS
KW - ANION-EXCHANGE
UR - http://www.scopus.com/inward/record.url?scp=84872231059&partnerID=8YFLogxK
U2 - 10.1089/hgtb.2012.059
DO - 10.1089/hgtb.2012.059
M3 - Article
C2 - 22934827
SN - 1946-6536
VL - 23
SP - 255
EP - 263
JO - Human Gene Therapy Methods
JF - Human Gene Therapy Methods
IS - 4
ER -